Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 907.4 DKK -0.75% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Novo Nordisk A/S?
Write Note

Relative Value

The Relative Value of one NOVO B stock under the Base Case scenario is hidden DKK. Compared to the current market price of 907.4 DKK, Novo Nordisk A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NOVO B Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
10
Median 3Y
10.6
Median 5Y
9.4
Industry
2.4
Forward
13.7
vs History
4
vs Industry
9
Median 3Y
32.7
Median 5Y
29
Industry
22.1
Forward
38.9
vs History
4
vs Industry
9
Median 3Y
24.6
Median 5Y
22.6
Industry
16.4
vs History
4
vs Industry
7
Median 3Y
29.9
Median 5Y
23.8
Industry
22.8
vs History
4
vs Industry
1
Median 3Y
23.2
Median 5Y
19.8
Industry
2
vs History
4
vs Industry
9
Median 3Y
10.6
Median 5Y
9.4
Industry
2.5
Forward
13.7
vs History
4
vs Industry
9
Median 3Y
12.8
Median 5Y
11.3
Industry
5.1
vs History
4
vs Industry
9
Median 3Y
22.9
Median 5Y
20.3
Industry
13.1
Forward
28.4
vs History
4
vs Industry
11
Median 3Y
25.2
Median 5Y
22.3
Industry
16.5
Forward
31.1
vs History
4
vs Industry
10
Median 3Y
24.5
Median 5Y
22.4
Industry
15.2
vs History
4
vs Industry
5
Median 3Y
32.1
Median 5Y
28
Industry
18
vs History
4
vs Industry
8
Median 3Y
9.6
Median 5Y
8.6
Industry
1.9

Multiples Across Competitors

NOVO B Competitors Multiples
Novo Nordisk A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.6 45.3 33.8 37
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
883B USD 22.8 120.7 60.1 67.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
381.7B USD 4.4 10 12.3 15.9
US
Merck & Co Inc
NYSE:MRK
284.9B USD 4.6 20.7 14 17.2
UK
AstraZeneca PLC
NASDAQ:AZN
256.9B USD 5.2 39.9 18.2 27.3
CH
Roche Holding AG
SIX:ROG
222.4B CHF 3.8 19.3 10.8 12.9
CH
Novartis AG
SIX:NOVN
191.1B CHF 4.5 13.7 10.8 16
US
Pfizer Inc
NYSE:PFE
163.7B USD 2.9 -63.1 12.7 20.6
IE
Endo International PLC
LSE:0Y5F
148.4B USD 64 -50.8 238.1 597
P/E Multiple
Earnings Growth
DK
Novo Nordisk A/S
CSE:NOVO B
Average P/E: 38.5
45.3
90%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
120.7
341%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
10
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 668%
UK
A
AstraZeneca PLC
NASDAQ:AZN
39.9
174%
CH
Roche Holding AG
SIX:ROG
19.3
29%
CH
Novartis AG
SIX:NOVN
13.7
20%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -63.1
693%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -50.8 N/A

See Also

Discover More
Back to Top